中兵紅箭(000519.SZ)半年度淨利潤預增64.25%-83.41%
格隆匯7月14日丨中兵紅箭(000519.SZ)公佈,預計2021年半年度歸屬於上市公司股東的淨利潤3億元-3.35億元,同比增長64.25%-83.41%。
2021年上半年,在公司董事會的堅強領導下,各子公司全面貫徹新發展理念,聚焦主責主業,堅持科技創新驅動,持續推動產品結構優化調整。認真研判市場發展變化,把握市場大勢,及時調整生產工藝以補足市場需求,總體經營質量和經營效益得到改善。
特種裝備方面,重點裝備科研項目穩步推進,生產經營和產品交付平穩有序開展。民品產品方面,堅持在優勢領域深挖發展潛力,以科技創新保持競爭優勢,以質量贏得客户,圍繞新產品拓展市場,持續推進降本增效,取得了良好的效果。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.